Evidence map›Paper›PMID 37034403›Full record

ArticleRSC chemical biology2023

Promoters

Shereen A Howpay Manage, Judy Zhu, Aaron M Fleming, Cynthia J Burrows

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Structural basis for nucleolin recognition ofScience (New York, N.Y.) · 2025
    Article
  7. Review
  8. Position-Dependent Effects of AP Sites Within anInternational journal of molecular sciences · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Nanoscale Interaction of Endonuclease APE1 with DNA.International journal of molecular sciences · 2024
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shereen A Howpay ManageDepartment of Chemistry, University of Utah 315 S. 1400 E. Salt Lake City UT 84112-0850 USA burrows@chem.utah.edu afleming@chem.utah.edu.
Judy ZhuDepartment of Chemistry, University of Utah 315 S. 1400 E. Salt Lake City UT 84112-0850 USA burrows@chem.utah.edu afleming@chem.utah.edu.
Aaron M FlemingDepartment of Chemistry, University of Utah 315 S. 1400 E. Salt Lake City UT 84112-0850 USA burrows@chem.utah.edu afleming@chem.utah.edu.
Cynthia J BurrowsDepartment of Chemistry, University of Utah 315 S. 1400 E. Salt Lake City UT 84112-0850 USA burrows@chem.utah.edu afleming@chem.utah.edu.ORCID https://orcid.org/0000-0001-7253-8529
University of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Chemistry and Biology of Oxidized Purine Lesions in DNAR01CA090689 · NCI · UNIVERSITY OF UTAH · PI BURROWS, CYNTHIA J, DAVID, SHEILA SUE · 2002 to 2019
$5.5M
Chemical Modifications in Regulatory Regions of DNA and RNAR35GM145237 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Cynthia J Burrows · 2022 to 2026
$2.3M
NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA090689NIGMS NIH HHS R35 GM145237
6 · The paper itself

Abstract

The DNA repair endonuclease APE1 is responsible for the cleavage of abasic sites (AP) in DNA as well as binding AP in promoter G-quadruplex (G4) folds in some genes to regulate transcription. The present studies focused on the topological properties of AP-bearing G4 folds and how they impact APE1 interaction. The human telomere sequence with a tetrahydrofuran model (F) of an AP was folded in K

Identifiers

PMID37034403
PMCPMC10074553
OpenAlexW4317206707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.